Search Results

Displaying Results 1-1 of 1 "'PSTV'"

Oct 15, 2025, 08:45 ET Cellular Immunotherapy Breakthroughs Fuel $370 Billion Market Surge

Therapeutics Limited (NASDAQ: GDTC), Plus Therapeutics, Inc. (NASDAQ: PSTV), Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), and I-Mab (NASDAQ:

More news about: Equity Insider


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.